Akero Therapeutics (AKRO) PT Lowered to $39 at UBS
Tweet
Share
E-mailGet Alerts AKRO Hot Sheet
Price: $54.74 --0%
Rating Summary:
12 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
12 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
UBS analyst Eliana Merle lowered the price target on Akero Therapeutics (NASDAQ: AKRO) to $39.00 (from $83.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- Climb Bio (CLYM) PT Raised to $25 at Baird
- CIENA (CIEN) PT Raised to $600 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
